Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

IACP Reports from Today's PCAC Meeting

Tuesday, March 8, 2016   (0 Comments)
Posted by: Dagmar Anderson
Share |


FDA's Pharmacy Compounding Advisory Committee (PCAC) voted this morning on the first two bulk ingredients: quinacrine hydrochloride and boswellia. Please keep in mind this is for the POSITIVE list. PCAC voted whether to add these bulk substances to the positive list and thus allow compounding with these bulk substances.


Should Quinacrine Hydrochloride be placed on the positive list?

Yes votes: 5
No votes: 6


Should Boswellia be placed on the positive list?

Yes votes: 0
No votes: 11 (whole committee)


PLEASE NOTE: These votes are NOT final. FDA must release final guidance for this to be FINAL. These are the Committee’s votes on FDA’s recommendations.

Association Management Software Powered by YourMembership  ::  Legal